[1]
Rushworth RL, Torpy DJ, Stratakis CA, Falhammar H. Adrenal Crises in Children: Perspectives and Research Directions. Hormone research in paediatrics. 2018:89(5):341-351. doi: 10.1159/000481660. Epub 2018 Jun 6
[PubMed PMID: 29874655]
Level 3 (low-level) evidence
[2]
Hahner S. Acute adrenal crisis and mortality in adrenal insufficiency: Still a concern in 2018! Annales d'endocrinologie. 2018 Jun:79(3):164-166. doi: 10.1016/j.ando.2018.04.015. Epub 2018 Apr 30
[PubMed PMID: 29716733]
[3]
Higham CE, Olsson-Brown A, Carroll P, Cooksley T, Larkin J, Lorigan P, Morganstein D, Trainer PJ, Society for Endocrinology Clinical Committee. SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy. Endocrine connections. 2018 Jul:7(7):G1-G7. doi: 10.1530/EC-18-0068. Epub
[PubMed PMID: 29930025]
[4]
Puar TH, Stikkelbroeck NM, Smans LC, Zelissen PM, Hermus AR. Adrenal Crisis: Still a Deadly Event in the 21st Century. The American journal of medicine. 2016 Mar:129(3):339.e1-9. doi: 10.1016/j.amjmed.2015.08.021. Epub 2015 Sep 9
[PubMed PMID: 26363354]
[5]
Rushworth RL, Torpy DJ, Falhammar H. Adrenal Crisis. The New England journal of medicine. 2019 Aug 29:381(9):852-861. doi: 10.1056/NEJMra1807486. Epub
[PubMed PMID: 31461595]
[6]
Upadhyay J, Sudhindra P, Abraham G, Trivedi N. Tuberculosis of the adrenal gland: a case report and review of the literature of infections of the adrenal gland. International journal of endocrinology. 2014:2014():876037. doi: 10.1155/2014/876037. Epub 2014 Aug 6
[PubMed PMID: 25165474]
Level 3 (low-level) evidence
[7]
Burns CM. The History of Cortisone Discovery and Development. Rheumatic diseases clinics of North America. 2016 Feb:42(1):1-14, vii. doi: 10.1016/j.rdc.2015.08.001. Epub
[PubMed PMID: 26611547]
[8]
Gidlöf S, Falhammar H, Thilén A, von Döbeln U, Ritzén M, Wedell A, Nordenström A. One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study. The lancet. Diabetes & endocrinology. 2013 Sep:1(1):35-42. doi: 10.1016/S2213-8587(13)70007-X. Epub 2013 Feb 26
[PubMed PMID: 24622265]
Level 2 (mid-level) evidence
[9]
Omori K, Nomura K, Shimizu S, Omori N, Takano K. Risk factors for adrenal crisis in patients with adrenal insufficiency. Endocrine journal. 2003 Dec:50(6):745-52
[PubMed PMID: 14709847]
[10]
Smans LC, Van der Valk ES, Hermus AR, Zelissen PM. Incidence of adrenal crisis in patients with adrenal insufficiency. Clinical endocrinology. 2016 Jan:84(1):17-22. doi: 10.1111/cen.12865. Epub 2015 Aug 27
[PubMed PMID: 26208266]
[11]
Bleicken B, Hahner S, Ventz M, Quinkler M. Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients. The American journal of the medical sciences. 2010 Jun:339(6):525-31. doi: 10.1097/MAJ.0b013e3181db6b7a. Epub
[PubMed PMID: 20400889]
Level 2 (mid-level) evidence
[12]
Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. The Journal of clinical endocrinology and metabolism. 2009 Dec:94(12):4882-90. doi: 10.1210/jc.2009-1368. Epub 2009 Oct 26
[PubMed PMID: 19858318]
[13]
Hahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D, Beuschlein F, Willenberg HS, Quinkler M, Allolio B. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. The Journal of clinical endocrinology and metabolism. 2015 Feb:100(2):407-16. doi: 10.1210/jc.2014-3191. Epub 2014 Nov 24
[PubMed PMID: 25419882]
[14]
Heidarpour M, Vakhshoori M, Abbasi S, Shafie D, Rezaei N. Adrenal insufficiency in coronavirus disease 2019: a case report. Journal of medical case reports. 2020 Aug 24:14(1):134. doi: 10.1186/s13256-020-02461-2. Epub 2020 Aug 24
[PubMed PMID: 32838801]
Level 3 (low-level) evidence
[15]
Hahner S, Loeffler M, Bleicken B, Drechsler C, Milovanovic D, Fassnacht M, Ventz M, Quinkler M, Allolio B. Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. European journal of endocrinology. 2010 Mar:162(3):597-602. doi: 10.1530/EJE-09-0884. Epub 2009 Dec 2
[PubMed PMID: 19955259]
[16]
Lousada LM, Mendonca BB, Bachega TASS. Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia. Archives of endocrinology and metabolism. 2021 Nov 3:65(4):488-494. doi: 10.20945/2359-3997000000392. Epub 2021 Jul 16
[PubMed PMID: 34283908]
[17]
Allolio B. Extensive expertise in endocrinology. Adrenal crisis. European journal of endocrinology. 2015 Mar:172(3):R115-24. doi: 10.1530/EJE-14-0824. Epub 2014 Oct 6
[PubMed PMID: 25288693]
[18]
Manaka K, Sato J, Takeuchi M, Watanabe K, Kage H, Kawai T, Sato Y, Miyagawa T, Yamada D, Kume H, Sato S, Nagase T, Iiri T, Nangaku M, Makita N. Immune checkpoint inhibitor combination therapies very frequently induce secondary adrenal insufficiency. Scientific reports. 2021 Jun 2:11(1):11617. doi: 10.1038/s41598-021-91032-6. Epub 2021 Jun 2
[PubMed PMID: 34078988]
[19]
Joshi MN, Whitelaw BC, Palomar MT, Wu Y, Carroll PV. Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review. Clinical endocrinology. 2016 Sep:85(3):331-9. doi: 10.1111/cen.13063. Epub 2016 Apr 13
[PubMed PMID: 26998595]
[20]
Elshimy G, Gandhi A, Guo R, Correa R. Tyrosine Kinase Inhibitors' Newly Reported Endocrine Side Effect: Pazopanib-Induced Primary Adrenal Insufficiency in a Patient With Metastatic Renal Cell Cancer. Journal of investigative medicine high impact case reports. 2020 Jan-Dec:8():2324709620936808. doi: 10.1177/2324709620936808. Epub
[PubMed PMID: 32583692]
Level 3 (low-level) evidence
[21]
Lodish MB. Clinical review: kinase inhibitors: adverse effects related to the endocrine system. The Journal of clinical endocrinology and metabolism. 2013 Apr:98(4):1333-42. doi: 10.1210/jc.2012-4085. Epub 2013 Feb 28
[PubMed PMID: 23450053]
[22]
Rushworth RL, Torpy DJ, Falhammar H. Adrenal crises: perspectives and research directions. Endocrine. 2017 Feb:55(2):336-345. doi: 10.1007/s12020-016-1204-2. Epub 2016 Dec 19
[PubMed PMID: 27995500]
Level 3 (low-level) evidence
[23]
White K, Arlt W. Adrenal crisis in treated Addison's disease: a predictable but under-managed event. European journal of endocrinology. 2010 Jan:162(1):115-20. doi: 10.1530/EJE-09-0559. Epub 2009 Sep 23
[PubMed PMID: 19776201]
[24]
Iwasaku M, Shinzawa M, Tanaka S, Kimachi K, Kawakami K. Clinical characteristics of adrenal crisis in adult population with and without predisposing chronic adrenal insufficiency: a retrospective cohort study. BMC endocrine disorders. 2017 Sep 11:17(1):58. doi: 10.1186/s12902-017-0208-0. Epub 2017 Sep 11
[PubMed PMID: 28893233]
Level 2 (mid-level) evidence
[26]
Bornstein SR. Predisposing factors for adrenal insufficiency. The New England journal of medicine. 2009 May 28:360(22):2328-39. doi: 10.1056/NEJMra0804635. Epub
[PubMed PMID: 19474430]
[27]
Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism. 2016 Feb:101(2):364-89. doi: 10.1210/jc.2015-1710. Epub 2016 Jan 13
[PubMed PMID: 26760044]
Level 1 (high-level) evidence
[28]
Shibata S, Kami M, Kanda Y, Machida U, Iwata H, Kishi Y, Takeshita A, Miyakoshi S, Ueyama J, Morinaga S, Mutou Y. Acute adrenal failure associated with fluconazole after administration of high-dose cyclophosphamide. American journal of hematology. 2001 Apr:66(4):303-5
[PubMed PMID: 11279645]
[29]
Orme LM, Bond JD, Humphrey MS, Zacharin MR, Downie PA, Jamsen KM, Mitchell SL, Robinson JM, Grapsas NA, Ashley DM. Megestrol acetate in pediatric oncology patients may lead to severe, symptomatic adrenal suppression. Cancer. 2003 Jul 15:98(2):397-405
[PubMed PMID: 12872362]
[30]
Naing KK, Dewar JA, Leese GP. Megestrol acetate therapy and secondary adrenal suppression. Cancer. 1999 Sep 15:86(6):1044-9
[PubMed PMID: 10491532]
[31]
Hellman L, Yoshida K, Zumoff B, Levin J, Kream J, Fukushima DK. The effect of medroxyprogesterone acetate on the pituitary-adrenal axis. The Journal of clinical endocrinology and metabolism. 1976 May:42(5):912-7
[PubMed PMID: 178684]
[32]
Yuen KC, Chong LE, Koch CA. Adrenal insufficiency in pregnancy: challenging issues in diagnosis and management. Endocrine. 2013 Oct:44(2):283-92. doi: 10.1007/s12020-013-9893-2. Epub 2013 Feb 2
[PubMed PMID: 23377701]
[33]
Tallis PH, Rushworth RL, Torpy DJ, Falhammar H. Adrenal insufficiency due to bilateral adrenal metastases - A systematic review and meta-analysis. Heliyon. 2019 May:5(5):e01783. doi: 10.1016/j.heliyon.2019.e01783. Epub 2019 May 29
[PubMed PMID: 31193734]
Level 1 (high-level) evidence
[34]
Ramon I, Mathian A, Bachelot A, Hervier B, Haroche J, Boutin-Le Thi Huong D, Costedoat-Chalumeau N, Wechsler B, Karmali R, Velkeniers B, Touraine P, Coussieu C, Bennani A, Renard-Penna R, Grenier PA, Wahl D, Piette JC, Amoura Z. Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome: long-term outcome of 16 patients. The Journal of clinical endocrinology and metabolism. 2013 Aug:98(8):3179-89. doi: 10.1210/jc.2012-4300. Epub 2013 Jun 19
[PubMed PMID: 23783099]
[35]
Bain A, Stewart M, Mwamure P, Nirmalaraj K. Addison's disease in a patient with hypothyroidism: autoimmune polyglandular syndrome type 2. BMJ case reports. 2015 Aug 3:2015():. doi: 10.1136/bcr-2015-210506. Epub 2015 Aug 3
[PubMed PMID: 26240101]
Level 3 (low-level) evidence
[36]
Puttanna A, Cunningham AR, Dainty P. Addison's disease and its associations. BMJ case reports. 2013 Jul 26:2013():. doi: 10.1136/bcr-2013-010473. Epub 2013 Jul 26
[PubMed PMID: 23893277]
Level 3 (low-level) evidence
[37]
Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine reviews. 2000 Feb:21(1):55-89
[PubMed PMID: 10696570]
[38]
Malbon CC, Rapiejko PJ, Watkins DC. Permissive hormone regulation of hormone-sensitive effector systems. Trends in pharmacological sciences. 1988 Jan:9(1):33-6
[PubMed PMID: 3072728]
[39]
Turnbull AV, Rivier C. Regulation of the HPA axis by cytokines. Brain, behavior, and immunity. 1995 Dec:9(4):253-75
[PubMed PMID: 8903845]
[40]
Bellavance MA, Rivest S. The HPA - Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain. Frontiers in immunology. 2014:5():136. doi: 10.3389/fimmu.2014.00136. Epub 2014 Mar 31
[PubMed PMID: 24744759]
[41]
Pariante CM, Pearce BD, Pisell TL, Sanchez CI, Po C, Su C, Miller AH. The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology. 1999 Sep:140(9):4359-66
[PubMed PMID: 10465310]
[42]
Quatrini L, Ugolini S. New insights into the cell- and tissue-specificity of glucocorticoid actions. Cellular & molecular immunology. 2021 Feb:18(2):269-278. doi: 10.1038/s41423-020-00526-2. Epub 2020 Aug 31
[PubMed PMID: 32868909]
[43]
Erkut ZA, Pool C, Swaab DF. Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. The Journal of clinical endocrinology and metabolism. 1998 Jun:83(6):2066-73
[PubMed PMID: 9626140]
[44]
Kim JK, Summer SN, Wood WM, Schrier RW. Role of glucocorticoid hormones in arginine vasopressin gene regulation. Biochemical and biophysical research communications. 2001 Dec 21:289(5):1252-6
[PubMed PMID: 11741329]
[45]
Kuo T, McQueen A, Chen TC, Wang JC. Regulation of Glucose Homeostasis by Glucocorticoids. Advances in experimental medicine and biology. 2015:872():99-126. doi: 10.1007/978-1-4939-2895-8_5. Epub
[PubMed PMID: 26215992]
Level 3 (low-level) evidence
[46]
Sominsky L, Spencer SJ. Eating behavior and stress: a pathway to obesity. Frontiers in psychology. 2014:5():434. doi: 10.3389/fpsyg.2014.00434. Epub 2014 May 13
[PubMed PMID: 24860541]
[47]
Bollag WB. Regulation of aldosterone synthesis and secretion. Comprehensive Physiology. 2014 Jul:4(3):1017-55. doi: 10.1002/cphy.c130037. Epub
[PubMed PMID: 24944029]
[48]
Esposito D, Pasquali D, Johannsson G. Primary Adrenal Insufficiency: Managing Mineralocorticoid Replacement Therapy. The Journal of clinical endocrinology and metabolism. 2018 Feb 1:103(2):376-387. doi: 10.1210/jc.2017-01928. Epub
[PubMed PMID: 29156052]
[49]
Claessen KMJA, Andela CD, Biermasz NR, Pereira AM. Clinical Unmet Needs in the Treatment of Adrenal Crisis: Importance of the Patient's Perspective. Frontiers in endocrinology. 2021:12():701365. doi: 10.3389/fendo.2021.701365. Epub 2021 Jul 20
[PubMed PMID: 34354671]
Level 3 (low-level) evidence
[50]
Dineen R, Thompson CJ, Sherlock M. Adrenal crisis: prevention and management in adult patients. Therapeutic advances in endocrinology and metabolism. 2019:10():2042018819848218. doi: 10.1177/2042018819848218. Epub 2019 Jun 13
[PubMed PMID: 31223468]
Level 3 (low-level) evidence
[51]
Robati S, Shahid MK, Vella A, Rang S. Importance of a thorough drug history in presurgical patients. BMJ case reports. 2014 Mar 14:2014():. doi: 10.1136/bcr-2013-202667. Epub 2014 Mar 14
[PubMed PMID: 24632903]
Level 3 (low-level) evidence
[52]
Dinsen S, Baslund B, Klose M, Rasmussen AK, Friis-Hansen L, Hilsted L, Feldt-Rasmussen U. Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself. European journal of internal medicine. 2013 Dec:24(8):714-20. doi: 10.1016/j.ejim.2013.05.014. Epub 2013 Jun 25
[PubMed PMID: 23806261]
[53]
Hopkins RL, Leinung MC. Exogenous Cushing's syndrome and glucocorticoid withdrawal. Endocrinology and metabolism clinics of North America. 2005 Jun:34(2):371-84, ix
[PubMed PMID: 15850848]
[54]
Kazlauskaite R, Evans AT, Villabona CV, Abdu TA, Ambrosi B, Atkinson AB, Choi CH, Clayton RN, Courtney CH, Gonc EN, Maghnie M, Rose SR, Soule SG, Tordjman K, Consortium for Evaluation of Corticotropin Test in Hypothalamic-Pituitary Adrenal Insufficiency. Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis. The Journal of clinical endocrinology and metabolism. 2008 Nov:93(11):4245-53. doi: 10.1210/jc.2008-0710. Epub 2008 Aug 12
[PubMed PMID: 18697868]
[56]
Malikova J, Flück CE. Novel insight into etiology, diagnosis and management of primary adrenal insufficiency. Hormone research in paediatrics. 2014:82(3):145-57. doi: 10.1159/000363107. Epub 2014 Aug 1
[PubMed PMID: 25096886]
[57]
Prete A, Taylor AE, Bancos I, Smith DJ, Foster MA, Kohler S, Fazal-Sanderson V, Komninos J, O'Neil DM, Vassiliadi DA, Mowatt CJ, Mihai R, Fallowfield JL, Annane D, Lord JM, Keevil BG, Wass JAH, Karavitaki N, Arlt W. Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery. The Journal of clinical endocrinology and metabolism. 2020 Jul 1:105(7):2262-74. doi: 10.1210/clinem/dgaa133. Epub
[PubMed PMID: 32170323]
[58]
Guignat L. Therapeutic patient education in adrenal insufficiency. Annales d'endocrinologie. 2018 Jun:79(3):167-173. doi: 10.1016/j.ando.2018.03.002. Epub 2018 Mar 29
[PubMed PMID: 29606279]
[59]
Shenker Y, Skatrud JB. Adrenal insufficiency in critically ill patients. American journal of respiratory and critical care medicine. 2001 Jun:163(7):1520-3
[PubMed PMID: 11401866]
[60]
Betterle C, Presotto F, Furmaniak J. Epidemiology, pathogenesis, and diagnosis of Addison's disease in adults. Journal of endocrinological investigation. 2019 Dec:42(12):1407-1433. doi: 10.1007/s40618-019-01079-6. Epub 2019 Jul 18
[PubMed PMID: 31321757]
[61]
Ngaosuwan K, Johnston DG, Godsland IF, Cox J, Majeed A, Quint JK, Oliver N, Robinson S. Increased Mortality Risk in Patients With Primary and Secondary Adrenal Insufficiency. The Journal of clinical endocrinology and metabolism. 2021 Jun 16:106(7):e2759-e2768. doi: 10.1210/clinem/dgab096. Epub
[PubMed PMID: 33596308]
[62]
Arlt W, Society for Endocrinology Clinical Committee. SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients. Endocrine connections. 2016 Sep:5(5):G1-G3
[PubMed PMID: 27935813]
[63]
Quinkler M,Hahner S, What is the best long-term management strategy for patients with primary adrenal insufficiency? Clinical endocrinology. 2012 Jan
[PubMed PMID: 21585418]
[64]
Woodcock T, Barker P, Daniel S, Fletcher S, Wass JAH, Tomlinson JW, Misra U, Dattani M, Arlt W, Vercueil A. Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia. 2020 May:75(5):654-663. doi: 10.1111/anae.14963. Epub 2020 Feb 3
[PubMed PMID: 32017012]
[65]
Burger-Stritt S, Kardonski P, Pulzer A, Meyer G, Quinkler M, Hahner S. Management of adrenal emergencies in educated patients with adrenal insufficiency-A prospective study. Clinical endocrinology. 2018 Jul:89(1):22-29. doi: 10.1111/cen.13608. Epub 2018 Apr 24
[PubMed PMID: 29617051]
[66]
Matsubayashi S, Nakatake N, Hara T. Possible adrenal insufficiency among fatigue patients in a psychosomatic medical clinic. Endocrine journal. 2020 Jan 28:67(1):53-57. doi: 10.1507/endocrj.EJ19-0096. Epub 2019 Oct 8
[PubMed PMID: 31597820]
[67]
White KG. A retrospective analysis of adrenal crisis in steroid-dependent patients: causes, frequency and outcomes. BMC endocrine disorders. 2019 Dec 2:19(1):129. doi: 10.1186/s12902-019-0459-z. Epub 2019 Dec 2
[PubMed PMID: 31791297]
Level 2 (mid-level) evidence